ScreenerHero
LKMNHLokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S.
BIST · TR · Healthcare · Medical Care Facilities · lokmanhekim.com.tr
13.77TRY-0.51%Mkt Cap: 71.49M $P/E: 21.29

Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S., together with its subsidiaries, operates hospitals, medical centers, laboratories, and medical units in Turkey. The company offers health c…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap71.49M $
Enterprise Value141.40M $
Revenue (TTM)118.36M $
Gross Profit17.93M $
Net Income (TTM)3.60M $
Revenue/Share0.4687 USD
Last Price13.77 TRY
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.4K
CountryTR
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)21.29
P/E (Forward)—
PEG—
EV/EBITDA4.89
EV/Revenue1.19
P/S0.60
P/B1.26
EPS (TTM)0.65
EPS (Forward)—
52W Range
12.8710% of range21.80
52W High21.80 TRY
52W Low12.87 TRY
Profitability
Gross Margin17.71%
Oper. Margin15.43%
EBITDA Margin24.41%
Profit Margin3.55%
ROE6.35%
ROA2.59%
Growth
Revenue Growth27.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.93M $
CapEx (TTM)22.81M $
FCF Margin-12.65%
FCF Yield-20.95%
Net Debt63.34M $
Net Debt/EBITDA2.19
Balance Sheet
Debt/Equity1.06
Current Ratio0.81
Quick Ratio0.47
Book Value/Sh10.95 TRY
Cash/Share0.2300 TRY
Dividends
Fwd Div Rate0.4600 TRY
Trail. Div Rate0.0000 TRY
Div. Yield3.39%
5Y Avg Yield1.43%
Payout Ratio64.30%
Ex-Div DateSep 28, 2026
Pay Date—
Splits
Last Split600:100
Split DateSep 18, 2024
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.64 TRY
Upside (mean)+64.4%
Target Range20.00 TRY – 25.27 TRY
TRY20.00+64.4% to meanTRY25.27
# Analysts2
Ownership
Shares Out.216.00M
Float214.26M
Insiders0.18%
Institutions1.01%
Technical
SMA 5014.65 (-6.0%)
SMA 20015.99 (-13.9%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)1.40M
Avg Vol (10d)1.84M
Technical Indicators
RSI (14)45.6
MACD-0.3181
MACD Signal-0.3610
MACD Hist.+0.0429
BB Upper14.73 TRY
BB Middle13.92 TRY
BB Lower13.12 TRY
BB Width11.55%
ATR (14)0.4760 TRY
Vol Ratio (20d)0.92x